Lupus Research Alliance News
Existing Cancer Drug May Lower Inflammation in Autoimmune Diseases Like Lupus

December 14, 2020 In a recent study published in the Journal of Immunology, LRA-funded researcher Dr. John Zhang at Medical University of South Carolina found that a protein called Fli-1 causes immune cells to produce a molecule that causes inflammation. When Fli-1 was hindered by the chemotherapeutic drug camptothecin, immune cells produced fewer inflammatory molecules. […] READ MORE

New Survey Shows Education and Communication Gaps in Lupus Nephritis Care

1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus New York, NY– December 7, 2020.  Significant gaps in education and communication among patients and physicians pose barriers to lupus nephritis (LN) care, according to results of two companion surveys conducted by the National Kidney Foundation (NKF) and the Lupus Research Alliance (LRA). Half […] READ MORE

LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome

December 2, 2020 The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according to a study partly funded by the Lupus Research Alliance. Dr. Jason Knight and his colleagues including rheumatologist Yu (Ray) Zuo and cardiologist Yogen Kanthi reported that 52% of patients hospitalized with severe COVID-19 had […] READ MORE

Give the Lupus Community a Priceless Gift on Giving Tuesday

November 30, 2020 Every year, on December 1, the world shows its heartfelt support for the Lupus Research Alliance and other non-profit organizations. Giving Tuesday “is a global generosity movement unleashing the power of people and organizations to transform their communities and the world.” Donate here to give the most priceless gift – research to […] READ MORE

Good News on Lupus Nephritis Discoveries from ACR Convergence 2020

November 19, 2020 The LRA is proud to share the extraordinary work presented at ACR Convergence 2020 by research members of the Accelerating Medicines Partnership Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) program (AMP RA/SLE).  AMP is a public-private partnership between the National Institutes of Health (NIH), eight biopharmaceutical companies, the LRA and several […] READ MORE

2021 Senate Budget Bill Includes Increases for Medical Research

November 11, 2020 The Lupus Research Alliance is pleased to share details of the 2021 spending package announced by the U.S. Senate last night with several potential “wins” for lupus research. While not 100% in line with our requests, funding for lupus research is substantial and due in large part to the hard work of […] READ MORE

Differences Found in Genes Among African and European Americans Point to Possible Lupus Drug Targets

November 10, 2020 Lupus affects individuals differently, from disease symptoms to responses to treatments.  Lupus patients of African ancestry often show significantly greater severity of lupus and respond to lupus drugs differently than lupus patients of European ancestry. In a collaboration among investigators at RILITE Foundation led by Dr. Peter Lipsky and Wake Forest School […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates